换一批
换一批Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.
作者：
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗原, CD34(Antigens, CD34);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨髓净化(Bone Marrow Purging);地塞米松(Dexamethasone);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);外周血干细胞移植(Peripheral Blood Stem Cell Transplantation);手术后并发症(Postoperative Complications);预后(Prognosis);复发(Recurrence);危险(Risk);存活率分析(Survival Analysis);存活率(Survival Rate);移植预处理(Transplantation Conditioning);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.3324/haematol.10535
PMID
17640853
发布时间
2019-06-08
- 浏览33
Haematologica
1083-90页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
